secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001104659-25-024408
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO John Dahldorf resigns; FULCRUM-VT trial enrollment exceeds 40%
------------------------------------------------------------------

- CFO John Dahldorf resigns effective March 21, 2025, no dispute over accounting; transitional CFO to be named.
- FULCRUM-VT pivotal study (vCLAS catheter) enrollment over 40%, on track for full enrollment H2 2025.
- Company to present ULTC data at EHRA 2025 (March 30-April 1) on scar-related VT and PVC ablation.
- Streamlining focus on ventricular tachycardia solutions; CEO notes sufficient financial resources to achieve goals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000110465925024408/0001104659-25-024408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000110465925024408/tm259258d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-024408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer